secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2024-07-05T23:59:59+00:00
Accession:  0001493152-24-026349
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell receives Nasdaq notice for failing $35M minimum MVLS requirement
-------------------------------------------------------------------------

- Received Nasdaq letter on July 3, 2024, for MVLS below $35M for 33 consecutive business days.
- Has until December 30, 2024 (180-day compliance period) to regain compliance.
- To regain compliance, MVLS must close at $35M+ for at least 10 consecutive business days.
- Failure could lead to delisting, with appeal rights to a Nasdaq Hearings Panel.
- Listing continues pending compliance; no immediate impact on trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224026349/0001493152-24-026349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224026349/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-026349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer